Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Mailstop U.S.12-4, 1600 Clifton Road, Atlanta, GA, 30333, USA.
J Immigr Minor Health. 2021 Aug;23(4):806-812. doi: 10.1007/s10903-020-01065-8.
Increased testing and treatment of latent tuberculosis infection (LTBI) among US-residents who were born (or lived) in countries with high rates of TB can hasten progress toward TB elimination. We calculated LTBI prevalence using QuantiFERON®-TB Gold In-Tube results from the 2011 to 2012 National Health and Nutrition Examination Survey (NHANES). LTBI prevalence was highest for persons born in India (31.7%, 95% confidence interval [21.2, 44.5]). Non-Hispanic white persons had the lowest LTBI prevalence (6.3% [1.9, 18.9]). TB reactivation rate, defined as the number of TB cases not associated with recent transmission per 100 person-years of life with LTBI, was highest for persons born in Vietnam [0.183 (0.117, 0.303)]. Reactivation rates were lower among persons who had resided in the United States for ≥ 10 years than among those who had resided for < 10 years. Results among high risk populations can guide LTBI targeted testing and treatment among non-U.S.-born residents.
增加对在美国出生(或居住)于结核病高发国家的居民进行潜伏性结核感染(LTBI)检测和治疗,可以加速结核病消除进程。我们利用 2011 至 2012 年全国健康和营养调查(NHANES)中的 QuantiFERON®-TB Gold In-Tube 检测结果计算 LTBI 的患病率。出生于印度的人群中 LTBI 的患病率最高(31.7% [21.2, 44.5])。非西班牙裔白人的 LTBI 患病率最低(6.3% [1.9, 18.9])。定义为每 100 人年 LTBI 相关结核病例数除以无近期传播的病例数的结核再激活率,在出生于越南的人群中最高[0.183 (0.117, 0.303)]。在美国居住时间≥10 年的人群的再激活率低于居住时间<10 年的人群。高危人群的结果可以指导非美国出生的居民进行 LTBI 靶向检测和治疗。